Breaking News
Investing Pro 0
Cyber Monday Deal: Up to 55% off CLAIM SALE
Close

Neurocrine Biosciences Inc (NBIX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Neurocrine's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
112.15 -0.87    -0.77%
15:40:17 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 63,125
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 111.83 - 113.43
Type:  Equity
Market:  United States
Neurocrine 112.15 -0.87 -0.77%

NASDAQ:NBIX Financials

 
See below for an overview of the Neurocrine financial reports. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:NBIX financials over time.

Neurocrine Biosciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 498.8 million compared to USD 387.9 million a year ago. Net income was USD 83.1 million compared to USD 68.5 million a year ago. Basic earnings per share from continuing operations was USD 0.85 compared to USD 0.72 a year ago. Diluted earnings per share from continuing operations was USD 0.82 compared to USD 0.69 a year ago.For the nine months, revenue was USD 1,371.9 million compared to USD 1,076.7 million a year ago. Net income was USD 102 million compared to USD 65.5 million a year ago. Basic earnings per share from continuing operations was USD 1.05 compared to USD 0.69 a year ago. Diluted earnings per share from continuing operations was USD 1.01 compared to USD 0.67 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

NBIX Income Statement

Gross margin TTM 67.24%
Operating margin TTM 19.5%
Net Profit margin TTM 10.71%
Return on Investment TTM 14.24%
 Total Revenue  Net Income
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Revenue 498.8 452.7 420.4 412
Gross Profit 345.4 295.4 272.4 286.3
Operating Income 141.2 73.6 29.7 103.4
Net Income 83.1 95.5 -76.6 89

NBIX Balance Sheet

Quick Ratio MRQ 2.19
Current Ratio MRQ 2.39
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 13.67%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Assets 2848.2 2613.1 2359.8 2368.7
Total Liabilities 846.1 760.1 675.3 660.9
Total Equity 2002.1 1853 1684.5 1707.8

NBIX Cash Flow Statement

Cash Flow/Share TTM 4.19
Revenue/Share TTM 18.27
Operating Cash Flow  30.65%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 212 179.6 -125.2 143
Cash From Investing Activities -97.3 -125.9 -42.1 -115.6
Cash From Financing Activities 18.8 2.9 8.2 24.6
Net Change in Cash 133.5 56.6 -159.1 50.7
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NBIX Comments

Write your thoughts about Neurocrine Biosciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Paul Liew
Paul Liew Aug 29, 2020 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2020.08.26 @ $116
Liew ST
Liew ST Aug 29, 2020 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
24/7. 2021Mar. $88. BOA Tgt $128
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email